Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report.
Front Immunol
; 13: 1047992, 2022.
Article
em En
| MEDLINE
| ID: mdl-36569904
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neuromielite Óptica
/
Agamaglobulinemia
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article